Infosys to drive innovation and create sustainable value as a RISE with SAP Validated Partner BENGALURU, India, April 29, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY) ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

On an adjusted basis, Regeneron earned $8.22 per share in the first quarter, below the average analyst estimate of $8.82, ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases. The agreement with Poseida is by ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Maital Shemesh-Rasmussen is the founder of Cox Rasmussen & Co., Inc. She currently holds the position of Independent Director at Pluri, Inc., Director at Healthcare Information & Management Systems ...

B2B is often seen to lag behind B2C in marketing, and nowhere is that more true than in the pharmaceuticals ... brand is more than just a logo - it’s your company’s reputation.